Stay updated on NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision stamp was updated to v3.6.3, replacing the previous v3.6.2. This indicates a general update to the page without altering the study data.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing v3.6.0, indicating a site update. The study content remains unchanged.SummaryDifference0.0%

- Check34 days agoChange DetectedThe study page now indicates that recruitment has ended and adds new help/navigation sections for readers. The Intervention/Treatment header formatting is updated and the revision version is bumped to v3.6.0.SummaryDifference0.4%

- Check41 days agoChange DetectedRevision v3.5.5 replaces v3.5.4 on the page, signaling an updated page template or back-end content update.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a backend or template update. No study content or data were modified as part of this change.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3 on the page, indicating a minor front-end/site update. No study data or user-facing content was modified.SummaryDifference0.0%

Stay in the know with updates to NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.